secwatch.observer — SEC 8-K summary
======================================

Issuer:     DarioHealth Corp. (DRIO)
CIK:        0001533998
Form:       8-K
Filed at:   2025-09-25T23:59:59+00:00
Accession:  0001104659-25-093431
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DarioHealth launches strategic review, raises $17.5M via private placement
--------------------------------------------------------------------------

- Board formed Special Committee, engaged Perella Weinberg as advisor to explore sale, merger, or standalone.
- Raised $17.5M gross via private placement of 1.15M shares and 1.56M pre-funded warrants at $6.45/share.
- Series C-1 Preferred mandatory conversion accelerated; holders receive common stock or pre-funded warrants plus dividends.
- Offering closed September 23, 2025; net proceeds for general corporate purposes.
- Strategic review follows multiple unsolicited inbound inquiries from interested parties.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533998/000110465925093431/0001104659-25-093431-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533998/000110465925093431/tm2526967d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-093431

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer